Eventually the debate will be over whether it should be Schedule 1, or whether there are acceptable medical uses for it.

This is actually one of the best long term ways for my business to wind down in 10-15 years.

Kratom has a very obvious medical use. It's an opioid and there is evidence that it has fewer side effects than morphine in mice (less constipation, and less "rewarding action" (euphoria) per unit of analgesia).

There is a patent pending for all possible derivatives of kratom: http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=/netahtml/PTO/srchnum.html&r=1&f=G&l=50&s1=%2220090221623%22.PGNR.&OS=DN/20090221623&RS=DN/20090221623

I think the debate will likely be about whether kratom derivatives should be schedule 2 or schedule 4.